Cargando…

Evaluation of clotrimazole prophylaxis on tacrolimus trough concentrations in kidney transplant recipients

BACKGROUND: Clotrimazole troches are used as prophylaxis against oropharyngeal candidiasis post‐transplant and have limited systemic absorption. Following several occurrences of tacrolimus concentration fluctuations after clotrimazole discontinuation, its use as prophylaxis was discontinued post‐kid...

Descripción completa

Detalles Bibliográficos
Autores principales: Wings, Emily, Spinner, Michael, Eckardt, Jamie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540224/
https://www.ncbi.nlm.nih.gov/pubmed/35689488
http://dx.doi.org/10.1111/tid.13882
_version_ 1784803663876718592
author Wings, Emily
Spinner, Michael
Eckardt, Jamie
author_facet Wings, Emily
Spinner, Michael
Eckardt, Jamie
author_sort Wings, Emily
collection PubMed
description BACKGROUND: Clotrimazole troches are used as prophylaxis against oropharyngeal candidiasis post‐transplant and have limited systemic absorption. Following several occurrences of tacrolimus concentration fluctuations after clotrimazole discontinuation, its use as prophylaxis was discontinued post‐kidney transplant. METHODS: We conducted a retrospective cohort study to evaluate the effect of clotrimazole prophylaxis on tacrolimus trough concentrations post‐kidney transplant. The study included adult patients who received a kidney transplant at Cleveland Clinic Main Campus from August 1, 2019 to July 1, 2020 and were maintained on per‐protocol, standard‐dose tacrolimus through 90 days post‐transplant. Patients were excluded if they received cyclosporine, systemic antifungals, strong CYP3A4 inhibitors or inducers, or a simultaneous multiorgan transplant. The primary objective was to compare tacrolimus trough concentrations before and after completion of clotrimazole prophylaxis. Secondary objectives were to compare the time to first post‐transplant goal tacrolimus trough concentration, the rate of for‐cause allograft biopsies within 90 days after transplant, and the incidence and type of candidiasis within 30 days after transplant, pre‐ and post‐protocol change. RESULTS: Following clotrimazole discontinuation, the median tacrolimus trough concentration decreased from 10.5 ng/ml (IQR 8.4–12.2) to 6.6 ng/ml (IQR 5–8.7, p < 0.0001). No statistically significant differences in the rate of for‐cause allograft biopsies (4.9% vs. 9.7%, p = 0.264) or incidence of candidiasis (1.2% vs. 5.4%, p = 0.217) were observed between those who received clotrimazole and those who did not receive clotrimazole. CONCLUSIONS: Our study provides further evidence of a significant drug–drug interaction between tacrolimus and clotrimazole among kidney transplant recipients that can potentially lead to negative allograft outcomes. [Image: see text]
format Online
Article
Text
id pubmed-9540224
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95402242022-10-14 Evaluation of clotrimazole prophylaxis on tacrolimus trough concentrations in kidney transplant recipients Wings, Emily Spinner, Michael Eckardt, Jamie Transpl Infect Dis Original Articles BACKGROUND: Clotrimazole troches are used as prophylaxis against oropharyngeal candidiasis post‐transplant and have limited systemic absorption. Following several occurrences of tacrolimus concentration fluctuations after clotrimazole discontinuation, its use as prophylaxis was discontinued post‐kidney transplant. METHODS: We conducted a retrospective cohort study to evaluate the effect of clotrimazole prophylaxis on tacrolimus trough concentrations post‐kidney transplant. The study included adult patients who received a kidney transplant at Cleveland Clinic Main Campus from August 1, 2019 to July 1, 2020 and were maintained on per‐protocol, standard‐dose tacrolimus through 90 days post‐transplant. Patients were excluded if they received cyclosporine, systemic antifungals, strong CYP3A4 inhibitors or inducers, or a simultaneous multiorgan transplant. The primary objective was to compare tacrolimus trough concentrations before and after completion of clotrimazole prophylaxis. Secondary objectives were to compare the time to first post‐transplant goal tacrolimus trough concentration, the rate of for‐cause allograft biopsies within 90 days after transplant, and the incidence and type of candidiasis within 30 days after transplant, pre‐ and post‐protocol change. RESULTS: Following clotrimazole discontinuation, the median tacrolimus trough concentration decreased from 10.5 ng/ml (IQR 8.4–12.2) to 6.6 ng/ml (IQR 5–8.7, p < 0.0001). No statistically significant differences in the rate of for‐cause allograft biopsies (4.9% vs. 9.7%, p = 0.264) or incidence of candidiasis (1.2% vs. 5.4%, p = 0.217) were observed between those who received clotrimazole and those who did not receive clotrimazole. CONCLUSIONS: Our study provides further evidence of a significant drug–drug interaction between tacrolimus and clotrimazole among kidney transplant recipients that can potentially lead to negative allograft outcomes. [Image: see text] John Wiley and Sons Inc. 2022-06-17 2022-08 /pmc/articles/PMC9540224/ /pubmed/35689488 http://dx.doi.org/10.1111/tid.13882 Text en © 2022 The Authors. Transplant Infectious Disease published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Wings, Emily
Spinner, Michael
Eckardt, Jamie
Evaluation of clotrimazole prophylaxis on tacrolimus trough concentrations in kidney transplant recipients
title Evaluation of clotrimazole prophylaxis on tacrolimus trough concentrations in kidney transplant recipients
title_full Evaluation of clotrimazole prophylaxis on tacrolimus trough concentrations in kidney transplant recipients
title_fullStr Evaluation of clotrimazole prophylaxis on tacrolimus trough concentrations in kidney transplant recipients
title_full_unstemmed Evaluation of clotrimazole prophylaxis on tacrolimus trough concentrations in kidney transplant recipients
title_short Evaluation of clotrimazole prophylaxis on tacrolimus trough concentrations in kidney transplant recipients
title_sort evaluation of clotrimazole prophylaxis on tacrolimus trough concentrations in kidney transplant recipients
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540224/
https://www.ncbi.nlm.nih.gov/pubmed/35689488
http://dx.doi.org/10.1111/tid.13882
work_keys_str_mv AT wingsemily evaluationofclotrimazoleprophylaxisontacrolimustroughconcentrationsinkidneytransplantrecipients
AT spinnermichael evaluationofclotrimazoleprophylaxisontacrolimustroughconcentrationsinkidneytransplantrecipients
AT eckardtjamie evaluationofclotrimazoleprophylaxisontacrolimustroughconcentrationsinkidneytransplantrecipients